SCHEMBL7702724

SCHEMBL7702724

CCCN(CCC)CCOc1cccc(-c2n[nH]c3c2Cc2ccccc2-3)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 11/20 0.53
CDK2 P24941 2/20 0.47
CDK1 P06493 1/20 0.47
CHEK1 O14757 6/20 0.46
PDGFRB P09619 1/20 0.43
HIF1A Q16665 1/20 0.42
KCNH2 Q12809 1/20 0.41
IKBKB O14920 1/20 0.40
MAP4K4 O95819 1/20 0.40
PIM1 P11309 1/20 0.40
RPS6KB1 P23443 1/20 0.40
MARK3 P27448 1/20 0.40
AKT1 P31749 1/20 0.40
AKT2 P31751 1/20 0.40
FLT3 P36888 1/20 0.40
RPS6KA3 P51812 1/20 0.40
PLK1 P53350 1/20 0.40
PRKAA1 Q13131 1/20 0.40
STK3 Q13188 1/20 0.40
MELK Q14680 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7702681 0.95 KDR (0.52) KDRCDK2CDK1CHEK1PDGFRB
SCHEMBL7136211 0.93 KDR (0.54) KDRCDK2CDK1CHEK1PDGFRB
SCHEMBL7144911 0.89 KDR (0.56) KDRCDK2CDK1CHEK1PDGFRB
SCHEMBL7703314 0.88 KDR (0.53) KDRCDK2CDK1CHEK1PDGFRB
SCHEMBL7700936 0.86 KDR (0.55) KDRCDK2CDK1CHEK1PDGFRB
SCHEMBL7002255 0.84 KDR (0.61) KDRCDK2CDK1CHEK1PDGFRB
SCHEMBL7147004 0.81 KDR (0.68) KDRCDK2CDK1CHEK1PDGFRB
SCHEMBL7700924 0.80 KDR (0.67) KDRCDK2CHEK1KCNH2MARK3
SCHEMBL7090397 0.80 KDR (0.50) KDRCDK2CDK1CHEK1PDGFRB
SCHEMBL7701562 0.80 KDR (0.44) KDRCDK2CDK1CHEK1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed